Abstract Fanconi anemia (FA) is an autosomal recessive disorder characterized by pancytopenia, predisposition to cancers, and a diverse variety of congenital malformations. At least eight complementation groups, A through H, have been described. Recently, the FA-A gene (FAA) has been isolated, and a large number of distinct mutations reported in ethnically diverse FA-A patients. Here, we report on the mutation analysis of five FA patients by single-strand conformation polymorphism. Out of five patients, at least three were found to have mutations in the FAA gene. The first patient was a compound heterozygote with a 1-bp deletion and a single-base substitution. The second patient had a heterozygous 2-bp deletion, which introduces a premature termination codon, and the third patient had a heterozygous splice donor site mutation in intron 27. 
Introduction
Fanconi anemia (FA) is an autosomal recessive disorder characterized by pancytopenia, skin pigmentation, a high incidence of lymphoid and other cancers, and a diverse variety of congenital malformations (Alter BP 1993; Andrea et al. 1997) . Cells from FA patients display chromosome instability (Liu et al. 1994) , spontaneous delay and arrest in the G 2 cell cycle checkpoint (Dutrillaux et al. 1982) , and increased sensitivity to DNA cross-linking agents (Strathdee et al. 1992a) . At least eight complementation groups (FA-A to FA-H) have been described . Among these groups, FA-A accounted for twothirds of 47 FA patients from European and US/Canadian populations (Buchwald 1995) . The underlying gene for FA-C (FAC) has been isolated and mapped to 9q22.3 (Strathdee et al. 1992b,c) . The gene responsible for FA-A (FAA) was isolated and mapped to 16q24.3 (Fanconi Anemia/Breast Cancer Consortium 1996; Lo Ten Foe et al. 1996) . The FAA gene showed no significant homology to any known genes; however, recent studies have demonstrated that (1) FAA protein binds to FAC protein (Kupfer et al. 1997a ) and (2) FAC protein is involved in cell cycle regulation via cyclin-dependent kinase cdc-2 (Kupfer et al. 1997b; Kruyt et al. 1997) . A large number of distinct mutations and polymorphisms have been reported in ethnically diverse FA-A patients (Savino et al. 1997; Levran et al. 1997) , suggesting the presence of genetic heterogeneity in FA-A patients. To search for mutations in the FAA gene in five Japanese FA patients, we screened the FAA cDNAs by single-strand conformation polymorphism (SSCP) analysis. Four novel mutations and two common polymorphisms were identified in three patients. and FA3IC (Chiba) are primary fibroblasts, while cell lines KCMC319 (Kanagawa) and SGL2952 (Saitama) are Epstein-Barr-(EB) transformed lymphoblastoid cells. All the patients, aged from 3 to 12 years old, had symptoms consistent with a diagnosis of FA, including pancytopenia, skin pigmentation, short stature, and congenital malformations. All families were unrelated. Hypersensitivity to mitomycin C (MMC) in the lymphoblastoid cell lines was confirmed by the MMC assay as described previously (Joenje et al. 1995) . The complementation groups to which the five patients belonged were unknown.
RT-PCR and SSCP analysis
FAA cDNA that included an open reading frame (ORF) was amplified by polymerase chain reaction (PCR) into 10 overlapping segments, and analyzed by SSCP. PCR primers were designed according to the published FAA cDNA sequence data (Table 1 ). In brief, total RNAs were extracted from FA cell lines using a TRIZOL Reagent (Gibco BRL, Gaithersburg, MD, USA). cDNA was synthesized from 10 µg of total RNA with 10 units of Moloney murine leukemia virus reverse transcriptase and 5 ng of random hexamer primers per microliter. One-tenth of the sample was amplified by PCR using primers end-labeled with [γ-32 P]ATP (Amersham U.K.). PCR conditions were 95°C for 5 min, followed by 35 cycles of 94°C for 1 min, 60°C for 1 min, and 72°C for 1 min, with a final extension time of 5 min at 72°C. The amplified products were digested with a restriction enzyme to give a size of 0.3 kb (Table 1) , and were electrophoresed on to a 5% nondenaturing polyacrylamide gel containing 5% glycerol at a constant temperature of 4°C or 15°C for 4 h. Heteroduplex bands were analyzed by autoradiography. The results were confirmed by two independent experiments.
Nucleotide sequencing
The SSCP variants were subjected to direct sequencing using fluorescent-labeled primers, SequiTherm EXCEL II Long Read DNA Sequencing Kits-LC (Epicentre Technologies WI, U.S.A.), and DNA sequencer 4000L (LI-COR NE, U.S.A.).
Results and discussion
To screen for mutations in five Japanese patients, FAA cDNA that included the 4365-bp ORF was amplified by PCR into 10 overlapping segments, and SSCP analysis followed by direct sequencing was carried out. Of five patients, three were found to have mutations in the FAA gene. Patient KCMC319 had a heterozygous 1-bp deletion and three kinds of heterozygous single-base substitutions. A 1-bp deletion, 2546delC, introduces a premature termination signal at codon 888 (Fig. 1a) . A C to T transition at nt position 3163 results in an Arg to Trp substitution at the 1055th residue (Fig. 1b) . No amino acid substitutions were observed in 50 normal Japanese individuals, suggesting that this is the missense mutation which could abolish the FAA protein function. The other two kinds of single-base substitutions were probably polymorphisms. A G to T transversion at nt position 1143 does not cause an amino acid substitution. Out of 100 normal chromosomes, 11 were found to have the transversion. A G to A transition at nt position 1501 introduces a Gln to Ser substitution at the 501st residue. We detected the transition in six of 100 normal Japanese chromosomes (Savino et al. 1997; Levran et al. 1997) . Taking the results together, we concluded that patient KCMC319 was a compound heterozygote with the deletion 2546delC and the substitution 3163C Ͼ T in the FAA gene. Patient FA3IC had a heterozygous 2-bp deletion, 978-979delGA. The deletion introduces a premature termination signal at codon 337 (Fig. 1c) . Patient FA1CH was found to have a heterozygous 6-bp deletion at nt position 2602-2607, which results in an in-frame two-amino acid deletion, 868-869delFQ. Nucleotide sequencing of intron 27 of the patient revealed that the deletion was derived from a splice acceptor site mutation, IVS27-2A Ͼ T (Fig.  1d) . No substitutions were detected in 50 Japanese controls, suggesting that the two-amino acid deletion could cause the FA phenotype, although we cannot exclude completely the possibility that it may represent a rare polymorphism. Functional analysis of the truncated FAA protein will resolve this problem. We could not detect any SSCP variants in other alleles of the patients (FA3IC and FA1CH), possibly due to the limitations of the technical procedure. Further studies including direct sequencing of the genomic DNAs will be needed. Three patients were found to have distinct mutations, suggesting the presence of genetic heterogeneity in Japanese FA-A patients. When we searched for mutations in the FAC cDNA of five Japanese patients; no SSCP variants were detected (data not shown). These results suggested that the relative prevalence of FA-A might also be high among Japanese FA patients. Continued screening for the FAA gene may provide a better understanding of the molecular basis of FA-A patients.
